RELLHIGH SIGNALOPERATIONAL10-K

Richardson Electronics completed a major business transformation by divesting its Healthcare division to DirectMed in January 2025, resulting in a 288% revenue surge but operational losses.

The healthcare asset sale represents a fundamental business restructuring that has dramatically increased the company's scale while maintaining a supply relationship with the buyer. The massive revenue growth coupled with operating losses suggests either integration challenges from the transaction or that the company is investing heavily in its remaining green energy and engineered solutions focus areas.

Comparing 2025-08-04 vs 2024-08-05View on EDGAR →
FINANCIAL ANALYSIS

Richardson's financials reflect a company in major transition, with revenue and gross profit both surging 288% following the healthcare divestiture, while the business moved from $348K operating income to a $2.5M operating loss. Despite operational challenges, the company strengthened its balance sheet with 48% higher cash levels and 62% improved operating cash flow, suggesting the underlying business transformation may be positioning the company for future profitability. The dramatic financial changes signal a complete business model shift that investors need to monitor closely for execution success.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
-807.8%
$348K-$2.5M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Gross Profit
P&L
+288.7%
$16.7M$64.8M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Revenue
P&L
+288.3%
$53.8M$208.9M

Strong top-line growth of 288.3% — accelerating demand or successful expansion into new markets.

Interest Expense
P&L
-99.3%
$141K$1K

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

Operating Cash Flow
Cash Flow
+61.7%
$6.5M$10.6M

Operating cash flow surged 61.7% — exceptional cash generation, highest quality earnings signal.

Cash & Equivalents
Balance Sheet
+48%
$24.3M$35.9M

Cash position surged 48% — strong cash generation or capital raise providing significant financial cushion.

Net Income
P&L
+44.4%
-$2.1M-$1.1M

Net income grew 44.4% — bottom-line growth signals improving overall business health.

Share Buybacks
Cash Flow
+27.1%
$3.9M$5.0M

Share repurchases increased 27.1% — management returning capital, signals confidence in intrinsic value.

Current Liabilities
Balance Sheet
+14.8%
$32.0M$36.8M

Current liabilities rose 14.8% — increased short-term obligations, watch current ratio.

Total Liabilities
Balance Sheet
+13.6%
$34.5M$39.2M

Liabilities increased 13.6% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2025-08-04
PRIOR — 2024-08-05
ADDED
As of July 28, 2025, there were outstanding 12,443,065 shares of Common Stock, $0.05 par value and 2,049,238 shares of Class B Common Stock, $0.05 par value, which are convertible into Common Stock of the registrant on a one-for-one basis.
Market for the Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 21 Item 6.
(the "Company," "we," "our") is a leading global manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions.
More than 55% of our products are manufactured in LaFox, Illinois, Marlborough, Massachusetts, or Donaueschingen, Germany, or by one of our manufacturing partners throughout the world.
All of our partners manufacture to our strict specifications and per our supplier code of conduct.
+7 more — sign up free →
REMOVED
As of July 26, 2024, there were outstanding 12,327,733 shares of Common Stock, $0.05 par value and 2,049,238 shares of Class B Common Stock, $0.05 par value, which are convertible into Common Stock of the registrant on a one-for-one basis.
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 20 Item 6.
(the "Company," "we," "our") is a leading global manufacturer of engineered solutions, power grid and microwave tubes and related consumables; power conversion and RF and microwave components; high-value replacement parts, tubes and service training for diagnostic imaging equipment; and customized display solutions.
Nearly 55% of our products are manufactured at our facilities located in LaFox, Illinois, Marlborough, Massachusetts and Donaueschingen, Germany, or by one of our manufacturing partners throughout the world.
Our fiscal year 2024 began on May 28, 2023 and ended on June 1, 2024, our fiscal year 2023 began on May 29, 2022 and ended on May 27, 2023 and our fiscal year 2022 began on May 30, 2021 and ended on May 28, 2022.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
HOFTHIGHHOFT completed a major divestiture of its Pulaski and Samuel Lawrence furniture ...
2026-04-17
CTRNHIGHCTRN underwent a dramatic operational turnaround with a complete repositioning f...
2026-04-15
ORBSHIGHORBS has undergone a complete business transformation from packaging and e-comme...
2026-04-15
BRFHHIGHBRFH completed a transformative acquisition of Arps Dairy in October 2025, drama...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →